• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jade Biosciences, Inc. - Common Stock (NQ:JBIO)

23.36 -0.77 (-3.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 555,324
Open 23.38
Bid (Size) 18.17 (100)
Ask (Size) 27.61 (100)
Prev. Close 24.13
Today's Range 22.14 - 24.81
52wk Range 6.565 - 28.00
Shares Outstanding 28,985,019
Dividend Yield 10.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120% ↗
May 13, 2026
This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical trials. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company ↗
May 13, 2026
This clinical-stage biotech develops targeted radiopharmaceutical therapies for cancer using a proprietary miniprotein platform. 
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance

Performance

YTD
+64.9%
+64.9%
1 Month
+21.3%
+21.3%
3 Month
+55.4%
+55.4%
6 Month
+118.3%
+118.3%
1 Year
+215.6%
+215.6%

More News

Read More
News headline image
Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally ↗
May 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 07, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 23, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
April 22, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 06, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences to Participate in Upcoming Conferences
February 11, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Announces $45 Million Private Placement
December 15, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
November 17, 2025
Via Benzinga
News headline image
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
November 08, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences to Participate in Upcoming Conferences
November 03, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
October 17, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
October 07, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Announces $135 Million Private Placement
October 07, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 01, 2025
Via Benzinga
News headline image
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
September 02, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences to Participate in Upcoming Conferences
August 25, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Jade Biosciences Posts Wider Loss in Q2 ↗
August 13, 2025
Via The Motley Fool
News headline image
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 13, 2025
From Jade Biosciences
Via GlobeNewswire
News headline image
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
July 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
July 17, 2025
Via Benzinga
News headline image
Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket ↗
July 17, 2025
Via Benzinga

Frequently Asked Questions

Is Jade Biosciences, Inc. - Common Stock publicly traded?
Yes, Jade Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Jade Biosciences, Inc. - Common Stock trade on?
Jade Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jade Biosciences, Inc. - Common Stock?
The ticker symbol for Jade Biosciences, Inc. - Common Stock is JBIO on the Nasdaq Stock Market
What is the current price of Jade Biosciences, Inc. - Common Stock?
The current price of Jade Biosciences, Inc. - Common Stock is 23.36
When was Jade Biosciences, Inc. - Common Stock last traded?
The last trade of Jade Biosciences, Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Jade Biosciences, Inc. - Common Stock?
The market capitalization of Jade Biosciences, Inc. - Common Stock is 676.95M
How many shares of Jade Biosciences, Inc. - Common Stock are outstanding?
Jade Biosciences, Inc. - Common Stock has 677M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap